Biocon was final buying and selling 3.24 per cent decrease at Rs 381.35 on the BSE.
Share worth of Biocon declined greater than three per cent on Friday, April 30, a day after the biopharmaceutical firm introduced its January-March quarter outcomes for the monetary 12 months 2020-21. On Friday, Biocon opened on the BSE at Rs 392, touching an intra day excessive of Rs 392 and an intra day low of Rs 380.55, within the buying and selling session up to now. According to a regulatory submitting by the agency to the BSE, Biocon’s web revenue soared 105 per cent to Rs 254 crore within the March quarter of fiscal 2020-21. (Also Read: Biocon Net Profit Jumps 105% To ₹ 254 Crore In March Quarter )
On the NSE, Biocon opened at Rs 391.80, touching an intra day excessive of Rs 391.80 and an intra day low of Rs 380.50, within the session up to now. It was final buying and selling 3.17 per cent decrease at Rs 381.40 on the NSE.
Biocon was final buying and selling 3.24 per cent decrease at Rs 381.35 on the BSE.
